3-Dimensional Pharmaceuticals Inc (Inactive)

3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases. The company has developed an integrated set of proprietary technologies called DiscoverWorks to accelerate and improve the drug discovery process. DiscoverWorks integrates high-throughput screening, combinatorial chemistry, and structure based design for efficient drug discovery using targets from genome sequencing. 3-Dimensional Pharmaceuticals uses DiscoverWorks to discover and develop drugs for its own pipeline and in collaboration with pharmaceutical and biotechnology companies. In February, the company promoted John M. Gill, Executive Vice President and Chief Financial Officer, to the position of chief operating officer. In March, Melinda Rudolph was appointed to the position of vice president and general counsel.

• Latest SEC Filings

External Links

• Johnson & Johnson Completes Acquisition of 3-Dimensional Pharmaceuticals, Inc. 2003
• SEC 15-12G Securities Registration Termination 2003